Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00057473 · ClinicalTrials.gov registry record · Phase 2
A Phase II Study of Carboplatin Plus Irinotecan Versus Irinotecan in Children With Refractory Solid Tumors
A Phase 2 study, sponsored by Bristol-Myers Squibb.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00057473: Completed Phase 2 study, sponsored by Bristol-Myers Squibb.
NCT00057473 is a Phase 2 study that has completed, run by Bristol-Myers Squibb. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00057473, a Phase 2 study, has completed, sponsored by Bristol-Myers Squibb.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
This clinical research study is being conducted to investigate the effectiveness of combining carboplatin and irinotecan, versus irinotecan alone, in treating children who have refractory solid tumors.
Interventions
- DRUG irinotecan
- DRUG carboplatin + irinotecan
Trial Details
| Field | Value |
|---|---|
| Start Date | 2003-02 |
| Est. Completion | 2004-02 |
| Phase | Phase 2 |
What the finished NCT00057473 record still lists
NCT00057473 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 2 interventions - of which irinotecan is the first listed.
NCT00057473 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00057473 about?
NCT00057473 is a clinical study titled "A Phase II Study of Carboplatin Plus Irinotecan Versus Irinotecan in Children With Refractory Solid Tumors". This clinical research study is being conducted to investigate the effectiveness of combining carboplatin and irinotecan, versus irinotecan alone, in treating children who have refractory solid tumors.
What is the current status of trial NCT00057473?
This trial is currently completed. It is a Phase 2 study. The study started on 2003-02. Estimated completion is 2004-02.
What interventions are being tested in trial NCT00057473?
The interventions under investigation include: irinotecan (DRUG), carboplatin + irinotecan (DRUG).
Who is sponsoring clinical trial NCT00057473?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia